October 03, 2016
Weil advised IMS Health Holdings, Inc., a leading global information and technology services company, in its definitive all-stock merger of equals with Quintiles Transnational Holdings Inc., the world’s largest provider of product development and integrated healthcare services. The equity market capitalization of the combined company is more than $17.6 billion. The merged company is now named Quintiles IMS Holdings, Inc. The deal closed October 03, 2016.
The Weil team that advised IMS was led by Mergers & Acquisitions partner Michael Aiello and included Mergers & Acquisitions partner Matthew Gilroy; Banking & Finance head Douglas Urquhart; Capital Markets partner Frank Adams; Technology & IP Transactions partner Charan Sandhu; Executive Compensation & Benefits head Paul Wessel; Mergers & Acquisitions associates Christina De Vuono, Maxwell Copelan, Sean Devaney, Dianna Lee, Megan Briskman and Francesca Cohen; Sarah Davis and Suhan Shim; Capital Markets associates Anthony Mascarenhas, Raghav Thapar and Alla Khabinskaya; Technology & IP Transactions associates Caroline Geiger and Mary Lentowski; Tax associate Joseph Reich; and Executive Compensation & Benefits associates Amanda Rosenblum and Franny Glick.